SAEGIS PHARMACEUTICALS
Saegis Pharmaceuticals is focused on the development of medicines that address behavioral disorders. The company has a pipeline of treatments for central nervous system diseases involving cognitive dysfunction, including Alzheimer’s disease, mild cognitive impairment, attention deficit hyperactivity disorder, and cognitive impairment associated with schizophrenia. It develops CNS therapeutics for patients facing memory loss and cognition deficits associated with aging, psychiatric disorders, and brain trauma. Saegis Pharmaceuticals was founded in 1999 and is based in Half Moon Bay, California.
SAEGIS PHARMACEUTICALS
Industry:
Biopharma Biotechnology Health Care Medical
Founded:
1999-01-01
Address:
Half Moon Bay, California, United States
Country:
United States
Website Url:
http://www.saegispharma.com
Total Employee:
1+
Status:
Active
Contact:
(650) 560-0210
Email Addresses:
[email protected]
Total Funding:
44 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Font Awesome
Similar Organizations
Okairos
Okairos AG is a biopharmaceutical company focused on the discovery and development of genetic T-cell vaccines, including hepatitis C virus.
Sorrento Therapeutics
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
Trius Therapeutics
Trius Therapeutics is focused on the development of innovative antibiotics for life-threatening infections.
Founder
Investors List
Versant Ventures
Versant Ventures investment in Series B - Saegis Pharmaceuticals
Sofinnova Investments
Sofinnova Investments investment in Series B - Saegis Pharmaceuticals
Polaris Partners
Polaris Partners investment in Series B - Saegis Pharmaceuticals
Sofinnova Partners
Sofinnova Partners investment in Series B - Saegis Pharmaceuticals
NeuroVentures
NeuroVentures investment in Series B - Saegis Pharmaceuticals
Technology Partners
Technology Partners investment in Series B - Saegis Pharmaceuticals
Sofinnova Investments
Sofinnova Investments investment in Series A - Saegis Pharmaceuticals
